Sweet flavor modifier

US9745293B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9745293-B2
Application numberUS-201715460103-A
CountryUS
Kind codeB2
Filing dateMar 15, 2017
Priority dateAug 6, 2012
Publication dateAug 29, 2017
Grant dateAug 29, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention includes compounds having structural formula (Ia): or salts or solvates thereof. These compounds are useful as sweet flavor modifiers. The present invention also includes compositions comprising the present compounds and methods of modulating the sweet taste of compositions.

First claim

Opening claim text (preview).

What is claims is: 1. A compound having structural Formula (Ia): or a salt or solvate thereof; wherein m is 4, and n is 0; or m is 3, and n is 1; or m and n are both 2; q is 0, 1, or 2; X is a covalent bond; Y is alkyl, substituted alkyl, carbocyclyl, substituted carbocyclyl, heterocyclyl, substituted heterocyclyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aralkyl, substituted aralkyl, heteroarylalkyl, or substituted heteroarylalkyl; and each R 2 is independently selected from the group consisting of alkyl, halo, hydroxyl, alkoxy, and haloalkyl, wherein the substituents of a moiety indicated as substituted are selected from the group consisting of —R a , halo, ═O, —OR b , —SR b , —NR c R c , trihalomethyl, —CF 3 , —CN, —OCN, —SCN, —NO, —NO 2 , —N 3 , —S(O) 2 R b , —S(O) 2 OR b , —OS(O) 2 R b , —OS(O) 2 OR b , —P(O)(OR b )(OR b ), —C(O)R b , —C(S)R b , —C(NR b )R b , —C(O)OR b , —C(S)OR b , —C(O)NR c R c , —C(NR b )NR c R c , —OC(O)R b , —OC(S)R b , —OC(O)OR b , —OC(S)OR b , —NR b C(O)R b , —NR b C(S)R b , —NR b C(O)OR b , —NR b C(S)OR b , —NR b C(O)NR c R c , —NR b C(NR b )R b and —NR b C(NR b )NR c R c , where R a is selected from the group consisting of alkyl, cycloalkyl, cycloheteroalkyl, aryl, arylalkyl, heteroaryl and heteroarylalkyl; each R b is independently hydrogen or R a ; and each R c is independently R b or alternatively, the two R c s may be taken together with the nitrogen atom to which they are bonded form a 4-, 5-, 6- or 7-membered cycloheteroalkyl which may optionally include from 1 to 4 of the same or different additional heteroatoms selected from the group consisting of O (oxygen), N (nitrogen) and S (sulfur). 2. The compound of claim 1 , which is represented by structural Formula (Ib): or a salt or solvate thereof. 3. The compound of claim 1 , which is represented by structural Formula (Id): or a salt or solvate thereof. 4. The compound of claim 1 , which is selected from the group consisting of or a salt or solvate thereof. 5. The compound of claim 1 , which is or a salt or solvate thereof. 6. The compound of claim 1 , which is selected from the group consisting of or a salt or solvate thereof. 7. The compound of claim 1 , which is selected from the group consisting of or a salt or solvate thereof. 8. The compound of claim 1 , wherein Y is alkyl, carbocyclyl, heterocyclyl, aryl, heteroaryl, aralkyl, or heteroarylalkyl. 9. The compound of claim 1 , wherein the substituents of a moiety indicated as substituted are selected from the group consisting of —R a , halo, —OR b , —SR b , trihalomethyl, —CF 3 , —CN, —S(O) 2 R b , —S(O) 2 OR b , —OS(O) 2 R b , —OS(O) 2 OR b , —P(O)(OR b )(OR b ), —C(O)R b , —C(S)R b , —C(NR b )R b , —C(O)OR b , —C(S)OR b , —OC(O)R b , —OC(S)R b , —OC(O)OR b , —OC(S)OR b , —NR b C(O)R b , —NR b C(S)R b , —NR b C(O)OR b , —NR b C(S)OR b , and —NR b C(NR b )R b , where R a is selected from the group consisting of alkyl, cycloalkyl, cycloheteroalkyl, aryl, arylalkyl, heteroaryl and heteroarylalkyl; each R b is independently hydrogen or R a . 10. The compound of claim 1 , wherein the substituents of a moiety indicated as substituted are selected from the group consisting of —R a , halo, trihalomethyl, —CF 3 , —CN, where R a is selected from the group consisting of alkyl, cycloalkyl, cycloheteroalkyl, aryl, arylalkyl, heteroaryl and heteroarylalkyl. 11. A compound having structural Formula (Ia): or a salt or solvate thereof; wherein m is 4, and n is 0; or m is 3, and n is 1; or m and n are both 2; q is 0, 1, or 2; X is a covalent bond or —NR 1 —; R 1 is hydrogen or C1 to C6 alkyl; Y is carbocyclyl, substituted carbocyclyl, heterocyclyl, substituted heterocyclyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aralkyl, substituted aralkyl, heteroarylalkyl, or substituted heteroarylalkyl; and each R 2 is independently selected from the group consisting of alkyl, halo, hydroxyl, alkoxy, and haloalkyl, wherein the substituents of a moiety indicated as substituted are selected from the group consisting of —R a , halo, ═O, —OR b , —SR b , —NR c R c , trihalomethyl, —CF 3 , —CN, —OCN, —SCN, —NO, —NO 2 , —N 3 , —S(O) 2 R b , —S(O) 2 OR b , —OS(O) 2 R b , —OS(O) 2 OR b , —P(O)(OR b )(OR b ), —C(O)R b , —C(S)R b , —C(NR b )R b , —C(O)OR b , —C(S)OR b , —C(O)NR c R c , —C(NR b )NR c R c , —OC(O)R b , —OC(S)R b , —OC(O)OR b , —OC(S)OR b , —NR b C(O)R b , —NR b C(S)R b , —NR b C(O)OR b , —NR b C(S)OR b , —NR b C(O)NR c R c , —NR b C(NR b )R b and —NR b C(NR b )NR c R c , where R a is selected from the group consisting of alkyl, cycloalkyl, cycloheteroalkyl, aryl, arylalkyl, heteroaryl and heteroarylalkyl; each R b is independently hydrogen or R a ; and each R c is independently R b or alternatively, the two R c s may be taken together with the nitrogen atom to which they are bonded form a 4-, 5-, 6- or 7-membered cycloheteroalkyl which may optionally include from 1 to 4 of the same or different additional heteroatoms selected from the group consisting of O (oxygen), N (nitrogen) and S (sulfur). 12. The compound of claim 11 , wherein Y is carbocyclyl, heterocyclyl, aryl, heteroaryl, aralkyl, or heteroarylalkyl. 13. The compound of claim 11 , wherein X is a covalent bond. 14. The compound of claim 11 , wherein the compound is represented by structural Formula (Ib): or a salt or solvate thereof. 15. The compound of claim 11 , wherein the compound is represented by structural Formula (Ic): or a salt or solvate thereof. 16. The compound of claim 11 , wherein the compound is represented by structural Formula (Id):

Assignees

Inventors

Classifications

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis · CPC title

  • C07D417/12Primary

    linked by a chain containing hetero atoms as chain links · CPC title

  • Sweeteners · CPC title

  • Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9745293B2 cover?
The present invention includes compounds having structural formula (Ia): or salts or solvates thereof. These compounds are useful as sweet flavor modifiers. The present invention also includes compositions comprising the present compounds and methods of modulating the sw…
Who is the assignee on this patent?
Senomyx Inc
What technology area does this patent fall under?
Primary CPC classification C07D417/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).